266 related articles for article (PubMed ID: 10197296)
1. Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy.
Grasela TH; Fiedler-Kelly J; Cox E; Womble GP; Risner ME; Chen C
J Clin Pharmacol; 1999 Apr; 39(4):373-84. PubMed ID: 10197296
[TBL] [Abstract][Full Text] [Related]
2. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Otoul C; De Smedt H; Stockis A
Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy.
Eriksson AS; Hoppu K; Nergårdh A; Boreus L
Epilepsia; 1996 Aug; 37(8):769-73. PubMed ID: 8764817
[TBL] [Abstract][Full Text] [Related]
4. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
5. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
Kaminow L; Schimschock JR; Hammer AE; Vuong A
Epilepsy Behav; 2003 Dec; 4(6):659-66. PubMed ID: 14698699
[TBL] [Abstract][Full Text] [Related]
6. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
Contin M; Riva R; Albani F; Avoni P; Baruzzi A
Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622
[TBL] [Abstract][Full Text] [Related]
7. Effect of antiepileptic drug comedication on lamotrigine concentrations.
Lovrić M; Čajić I; Petelin Gadže Ž; Klarica Domjanović I; Božina N
Croat Med J; 2018 Feb; 59(1):13-19. PubMed ID: 29498493
[TBL] [Abstract][Full Text] [Related]
8. Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoin.
Anderson GD; Gidal BE; Messenheimer JA; Gilliam FG
Epilepsy Res; 2002 May; 49(3):211-7. PubMed ID: 12076842
[TBL] [Abstract][Full Text] [Related]
9. Effect of antiepileptic drug comedication on lamotrigine clearance.
Weintraub D; Buchsbaum R; Resor SR; Hirsch LJ
Arch Neurol; 2005 Sep; 62(9):1432-6. PubMed ID: 16157751
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of lamotrigine in children in the absence of other antiepileptic drugs.
Chen C; Casale EJ; Duncan B; Culverhouse EH; Gilman J
Pharmacotherapy; 1999 Apr; 19(4):437-41. PubMed ID: 10212015
[TBL] [Abstract][Full Text] [Related]
11. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
[TBL] [Abstract][Full Text] [Related]
12. Effect of comedication on lamotrigine clearance in Korean epilepsy patients.
Kim HJ; Kim TE; Joo EY; Seo DW; Lee SY; Hong SB
Clin Chim Acta; 2015 Jan; 438():269-73. PubMed ID: 25218785
[TBL] [Abstract][Full Text] [Related]
13. Age and comedications influence levetiracetam pharmacokinetics in children.
Dahlin MG; Wide K; Ohman I
Pediatr Neurol; 2010 Oct; 43(4):231-5. PubMed ID: 20837299
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
Battino D; Estienne M; Avanzini G
Clin Pharmacokinet; 1995 Nov; 29(5):341-69. PubMed ID: 8582119
[TBL] [Abstract][Full Text] [Related]
15. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial.
Berg M; Welty TE; Gidal BE; Diaz FJ; Krebill R; Szaflarski JP; Dworetzky BA; Pollard JR; Elder EJ; Jiang W; Jiang X; Switzer RD; Privitera MD
JAMA Neurol; 2017 Aug; 74(8):919-926. PubMed ID: 28654954
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data.
Hussein Z; Posner J
Br J Clin Pharmacol; 1997 May; 43(5):457-65. PubMed ID: 9159559
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy.
Biton V
Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):1009-18. PubMed ID: 17125413
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine clinical pharmacokinetics.
Rambeck B; Wolf P
Clin Pharmacokinet; 1993 Dec; 25(6):433-43. PubMed ID: 8119045
[TBL] [Abstract][Full Text] [Related]
20. Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy.
Jawad S; Yuen WC; Peck AW; Hamilton MJ; Oxley JR; Richens A
Epilepsy Res; 1987 May; 1(3):194-201. PubMed ID: 3504397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
